These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4708217)

  • 1. The chemotherapy of malignant melanoma in Nebraska.
    Foley JF; Lemon HM; Kessinger A
    Nebr Med J; 1973 Jun; 58(6):188-96. PubMed ID: 4708217
    [No Abstract]   [Full Text] [Related]  

  • 2. Dacarbazine for malignant melanoma.
    Med Lett Drugs Ther; 1974 Mar; 16(6):27-8. PubMed ID: 4817357
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.
    Gutterman JU; Mavligit G; Gottlieb JA; Burgess MA; McBride CE; Einhorn L; Freireich EJ; Hersh EM
    N Engl J Med; 1974 Sep; 291(12):592-7. PubMed ID: 4851001
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapy of malignant melanoma].
    Wagenknecht L
    Schweiz Med Wochenschr; 1973 Oct; 103(41):1426-8. PubMed ID: 4127413
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno) on immunity in patients with malignant melanoma.
    Bruckner HW; Mokyr MB; Mitchell MS
    Cancer Res; 1974 Jan; 34(1):181-3. PubMed ID: 4588545
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.
    Falkson G; Van der Merwe AM; Falkson HC
    Cancer Chemother Rep; 1972 Oct; 56(5):671-7. PubMed ID: 4569061
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and dactinomycin.
    Gerner RE; Moore GE; Didolkar MS
    Cancer; 1973 Oct; 32(4):756-60. PubMed ID: 4751912
    [No Abstract]   [Full Text] [Related]  

  • 8. Study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with disseminated melanoma.
    Gerner RE; Moore GE
    Cancer Chemother Rep; 1973 Feb; 57(1):83-4. PubMed ID: 4704107
    [No Abstract]   [Full Text] [Related]  

  • 9. Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma.
    Nathanson L; Wolter J; Horton J; Colsky J; Shnider BI; Schilling A
    Clin Pharmacol Ther; 1971; 12(6):955-62. PubMed ID: 5134998
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea.
    Costanza ME; Nathanson L; Lenhard R; Wolter J; Colsky J; Oberfield RA; Schilling A
    Cancer; 1972 Dec; 30(6):1457-61. PubMed ID: 4641757
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy of malignant melanoma.
    Luce JK
    Cancer; 1972 Dec; 30(6):1604-15. PubMed ID: 4565819
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recent diagnostic and therapeutic acquisitions in malignant melanoma].
    Paparopoli G; Sciarrino E
    Cancro; 1974; 27(1):15-20. PubMed ID: 4845209
    [No Abstract]   [Full Text] [Related]  

  • 13. Approaches to combination chemotherapy in rat, mouse, and hamster tumors.
    Griswold DP; Dykes DJ; Kelley CA; Roberts BJ; Dominick CA
    Cancer Chemother Rep 2; 1974 Mar; 4(1):99-108. PubMed ID: 4524043
    [No Abstract]   [Full Text] [Related]  

  • 14. Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma.
    Einhorn LH; McBride CM; Luce JK; Caoili E; Gottlieb JA
    Cancer; 1973 Oct; 32(4):749-55. PubMed ID: 4751911
    [No Abstract]   [Full Text] [Related]  

  • 15. Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
    Gams RA; Carpenter JT
    Cancer Chemother Rep; 1974; 58(5 Pt 1):753-4. PubMed ID: 4214608
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer; 1974 Mar; 33(3):615-8. PubMed ID: 4131357
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Chemotherapy of soft-tissue sarcomas.
    Talley RW
    Proc Natl Cancer Conf; 1972; 7():89-900. PubMed ID: 4358072
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Treatment of malignant melanoma.
    Gutterman JU; Mavligit GM; Reed RC; Hersh EM
    Lancet; 1974 Dec; 2(7894):1460. PubMed ID: 4140384
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic correlations and response to treatment in advanced metastatic malignant melanoma.
    Einhorn LH; Burgess MA; Vallejos C; Bodey GP; Gutterman J; Mavligit G; Hersh EM; Luce JK; Frei E; Freireich EJ; Gottlieb JA
    Cancer Res; 1974 Aug; 34(8):1995-2004. PubMed ID: 4842252
    [No Abstract]   [Full Text] [Related]  

  • 20. 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.
    Carter SK; Friedman MA
    Eur J Cancer (1965); 1972 Feb; 8(1):85-92. PubMed ID: 4552317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.